rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Report

China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 28, 2023
  • PAGES：201
  • REPORT CODE：GMM1762916
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Cigna

    • Sun Pharmaceutical Industries Ltd

    • LUPIN

    • Ferring Pharmaceuticals Inc

    • Fresenius Kabi AG

    • Merck & Co, Inc

    • Scripps Laboratories

    • Lee BioSolutions Inc

    • Abnova

    By Type:

    • rh-FSH (Recombinant Human Follitropin)

    • rHCG (recombinant Human Chorionic Gonadotropin)

    By Application:

    • Male

    • Female

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Overview 2018-2029

    • 1.1 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Development Overview

    • 1.2 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Development History

    • 1.3 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Market Size (2018-2029)

    • 1.4 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis by Type from Production Side

      • 1.4.1 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume, Production Value and Growth Rate of rh-FSH (Recombinant Human Follitropin) (2018-2029)

      • 1.4.2 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume, Production Value and Growth Rate of rHCG (recombinant Human Chorionic Gonadotropin) (2018-2029)

    • 1.5 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis by Application from Consumption End

      • 1.5.1 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume, Sales Value and Growth Rate of Male (2018-2029)

      • 1.5.2 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume, Sales Value and Growth Rate of Female (2018-2029)

    • 1.6 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis by Region

      • 1.6.1 North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

    Chapter 2 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Status and Competition Analysis in 2023

      • 2.2.3 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Development

    Chapter 3 rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin)Industry Chain Analysis

    • 3.1 rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Chain

    • 3.2 rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market

    • 3.3 rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market

    Chapter 4 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Type

    • 4.1 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Total Production Volume and Growth Rate from Production Side

    • 4.5 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume and Growth Rate, by Type

      • 4.5.1 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume and Growth Rate of rh-FSH (Recombinant Human Follitropin)

      • 4.5.2 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume and Growth Rate of rHCG (recombinant Human Chorionic Gonadotropin)

    Chapter 5 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Total Market Size and Growth Rate from Consumption End

    • 5.5 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate, by Application

      • 5.5.1 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate of Male

      • 5.5.2 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate of Female

    Chapter 6 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Region

    • 6.1 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume and Production Value, by Region

    • 6.2 China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume and Sales Value, by Region

    Chapter 7 North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis

    • 7.1 North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Type

    • 7.2 North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Application

    Chapter 8 Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis

    • 8.1 Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Type

    • 8.2 Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Application

    Chapter 9 South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis

    • 9.1 South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Type

    • 9.2 South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Application

    Chapter 10 East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis

    • 10.1 East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Type

    • 10.2 East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Application

    Chapter 11 Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis

    • 11.1 Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Type

    • 11.2 Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Application

    Chapter 12 Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis

    • 12.1 Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Type

    • 12.2 Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Application

    Chapter 13 Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Analysis

    • 13.1 Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Type

    • 13.2 Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Cigna

        • 14.1.1 Cigna Company Profile

        • 14.1.2 Cigna rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sun Pharmaceutical Industries Ltd

        • 14.2.1 Sun Pharmaceutical Industries Ltd Company Profile

        • 14.2.2 Sun Pharmaceutical Industries Ltd rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 LUPIN

        • 14.3.1 LUPIN Company Profile

        • 14.3.2 LUPIN rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Ferring Pharmaceuticals Inc

        • 14.4.1 Ferring Pharmaceuticals Inc Company Profile

        • 14.4.2 Ferring Pharmaceuticals Inc rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Fresenius Kabi AG

        • 14.5.1 Fresenius Kabi AG Company Profile

        • 14.5.2 Fresenius Kabi AG rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Merck & Co, Inc

        • 14.6.1 Merck & Co, Inc Company Profile

        • 14.6.2 Merck & Co, Inc rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Scripps Laboratories

        • 14.7.1 Scripps Laboratories Company Profile

        • 14.7.2 Scripps Laboratories rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Lee BioSolutions Inc

        • 14.8.1 Lee BioSolutions Inc Company Profile

        • 14.8.2 Lee BioSolutions Inc rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Abnova

        • 14.9.1 Abnova Company Profile

        • 14.9.2 Abnova rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Research Conclusions

    • 15.2 rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Market Size (2018-2029)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume, Production Value and Growth Rate of rh-FSH (Recombinant Human Follitropin) (2018-2029)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume, Production Value and Growth Rate of rHCG (recombinant Human Chorionic Gonadotropin) (2018-2029)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume, Sales Value and Growth Rate of Male (2018-2029)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume, Sales Value and Growth Rate of Female (2018-2029)

    • Figure North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

    • Figure Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

    • Figure South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

    • Figure East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate from 2018-2029

    • Figure rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Share by Type in 2018

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Share by Type in 2023

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume and Growth Rate of rh-FSH (Recombinant Human Follitropin) (2018-2023)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume and Growth Rate of rHCG (recombinant Human Chorionic Gonadotropin) (2018-2023)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Share by Application in 2018

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Share by Application in 2023

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Total Market Size and Growth Rate from Consumption End

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate of Male (2018-2023)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Market Size and Growth Rate of Female (2018-2023)

    • Table China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume by Region (2018-2023)

    • Table China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Region (2018-2023)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Region (2018-2023)

    • Table China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Value by Region (2018-2023)

    • Table China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Value Share by Region (2018-2023)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Value Share by Region (2018-2023)

    • Table China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume by Region (2018-2023)

    • Table China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Region (2018-2023)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Region (2018-2023)

    • Table China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Value by Region (2018-2023)

    • Table China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Value Share by Region (2018-2023)

    • Figure China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Value Share by Region (2018-2023)

    • Table North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume by Type (2018-2023)

    • Table North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Figure North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Table North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume by Application (2018-2023)

    • Table North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Figure North China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Table Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume by Type (2018-2023)

    • Table Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Figure Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Table Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume by Application (2018-2023)

    • Table Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Figure Central China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Table South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume by Type (2018-2023)

    • Table South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Figure South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Table South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume by Application (2018-2023)

    • Table South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Figure South China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Table East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume by Type (2018-2023)

    • Table East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Figure East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Table East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume by Application (2018-2023)

    • Table East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Figure East China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Table Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume by Type (2018-2023)

    • Table Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Figure Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Table Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume by Application (2018-2023)

    • Table Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Table Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume by Type (2018-2023)

    • Table Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Figure Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Table Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume by Application (2018-2023)

    • Table Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Table Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume by Type (2018-2023)

    • Table Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Figure Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Production Volume Share by Type (2018-2023)

    • Table Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume by Application (2018-2023)

    • Table Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Sales Volume Share by Application (2018-2023)

    • Table Cigna Company Profile

    • Table Cigna rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Revenue, Price and Gross (2018-2023)

    • Table Sun Pharmaceutical Industries Ltd Company Profile

    • Table Sun Pharmaceutical Industries Ltd rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Revenue, Price and Gross (2018-2023)

    • Table LUPIN Company Profile

    • Table LUPIN rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Revenue, Price and Gross (2018-2023)

    • Table Ferring Pharmaceuticals Inc Company Profile

    • Table Ferring Pharmaceuticals Inc rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Revenue, Price and Gross (2018-2023)

    • Table Fresenius Kabi AG Company Profile

    • Table Fresenius Kabi AG rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Revenue, Price and Gross (2018-2023)

    • Table Scripps Laboratories Company Profile

    • Table Scripps Laboratories rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Revenue, Price and Gross (2018-2023)

    • Table Lee BioSolutions Inc Company Profile

    • Table Lee BioSolutions Inc rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Revenue, Price and Gross (2018-2023)

    • Table Abnova Company Profile

    • Table Abnova rHCG (recombinant Human Chorionic Gonadotropin) and rh-FSH (Recombinant Human Follitropin) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US